Market Size Estimation Methodology:
A detailed market estimation approach was followed to estimate and validate the size of the global Fertility Testing Procedure Market and other dependent submarkets.
# The key players in the global fertility test market were identified through secondary research, and their global market shares were determined through primary and secondary research.
# The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global fertility test market.
# All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
# All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Download PDF [email protected]
Based on Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020
Based on the application, the fFertility Testing Procedure Market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.
# February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.
# May 2019, Fertility Focus (UK) launched an updated version of OvuSense App— OvuSense App v.2—with features such as increased flexibility in data viewing (three different ways), more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.
# January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), completed the acquisition of the e.p.t OTC pregnancy.
The home care settings segment is expected to register the highest CAGR during the forecast period
Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.
North America dominated the global fertilty test market in 2020
North America, comprising the US and Canada, accounted for the largest share of the Fertility Testing Procedure Market in 2020. The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.
Request Sample [email protected]
Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.
Major Growth Restraint: Lesser precision of ovulation prediction kits
Ovulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24–36 hours prior to ovulation. These kits, however, cannot accurately confirm ovulation. In conditions such as luteinized unruptured follicle syndrome (in which a woman’s egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results. Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.
Ovulation monitors can only test LH and do not identify other important ovulation signs, such as whether the cervical mucus is conductive for fertilization. Also, these monitors do not work when certain fertility drugs, such as Pergonal or the hormone hCG (Human Chorionic Gonadotropin), are present in the urine. Another major drawback of these kits is that they do not function for women in their 40s (specifically those approaching menopause) as they have increased levels of LH. These disadvantages of ovulation monitors limit their predictive capabilities and thus are restricting their adoption among end users.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441